Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$17.95 - $25.56 $1,795 - $2,556
-100 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$20.53 - $25.22 $2,053 - $2,522
100 New
100 $2,000
Q2 2020

Jul 29, 2020

SELL
$16.46 - $27.42 $1,646 - $2,742
-100 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$18.56 - $22.45 $5,568 - $6,735
-300 Reduced 75.0%
100 $2,000
Q3 2017

Nov 15, 2017

BUY
$23.35 - $29.24 $9,340 - $11,696
400
400 $10,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $9.25B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.